Loading clinical trials...

Sun Protection Factor Assay (319/2016) | Clinical Trials | Clareo Health

TERMINATEDNA

Sun Protection Factor Assay (319/2016)

Sun Protection Factor (SPF) Assay: UVA Protection Factor Assay Minimal Persistent Pigment-Darkening Dose

NCT02995044•Bayer

View on ClinicalTrials.gov

Summary

To evaluate the Sun Protection Factor efficacy on human skin.

Eligibility

Age

18 - 70 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Fitzpatrick Skin Type l, ll and/or lll for UVB testing. Fitzpatrick Skin Type ll, lll and/or lV for UVA testing.
•Male and female.
•Aged between 18-70 years old.
•Good health as determined from the HRL SHF (Subject History Form).
•Signed and dated Informed Consent Form.
•Signed and dated HIPAA (Health Insurance Portability and Accountability Act) form.
•An unambiguous MED (Minimal Erythema Dose) or MPPD (Minimal Persistent Pigment Darkening Dose).

Exclusion Criteria

•Subjects on test at any other research laboratory or clinic.
•Known allergy or sensitivity to sunscreens, cosmetics and toiletries, topical drugs and/or ultraviolet light.
•Pre-existing dermatologic conditions which have been diagnosed by a medical professional (e.g. psoriasis, eczema, etc.) which would interfere with this study.
•Pre-existing other medical conditions (e.g. adult asthma, diabetes).
•Treatment with antihistamines or corticosteroids within one week prior to initiation of the test.
•Treatment with antibiotics within two weeks prior to initiation of the test.
•Chronic medication which could affect the results of the study.
•Known pregnant or nursing women.

Locations (1)

Union, New Jersey, United States

Key Dates

Start Date

January 4, 2017

Primary Completion Date

January 6, 2017

Completion Date

January 6, 2017

Last Updated

February 27, 2018

Enrollment

ACTUAL participants

Conditions

Sunscreening Agents

Interventions

BAY987521

DRUG

SPF Control

DRUG

Bemotrizinol UV Filter Part 1 Clinical PK Evaluation in Topical MUsT Study

NCT04355286

Absorption; ChemicalsSunscreening Agents

View study

COMPLETEDNA

Sun Protection Factor Assay (SPF Assay 200/2016)

NCT02930759

Sunscreening Agents

View study

COMPLETEDNA

Human Phototoxicity Test (823/2016)

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 27, 2018Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Sun Protection Factor Assay (319/2016)

Inclusion Criteria

Exclusion Criteria

Bemotrizinol UV Filter Part 1 Clinical PK Evaluation in Topical MUsT Study

Sun Protection Factor Assay (SPF Assay 200/2016)

Human Phototoxicity Test (823/2016)

Human Photoallergy Test (824/2016)

Human Phototoxicity Test

Sun Protection Factor Assay